page contents

Johnson & Johnson beats first-quarter earnings, revenue estimates

Johnson & Johnson reported quarterly earnings and revenue that beat analysts’ expectations even as it faces litigation over its talc baby powder and new competition against its prostate cancer drug Zytiga.

div > div.group > p:first-child”> …
Business News

Leave a Reply

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close